PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that data from the Phase 3 pivotal studies of investigational drug Crisaborole Topical Ointment, 2% will be presented at two upcoming
The Fall Clinical Dermatology Conference, October 1-4, 2015 in Las Vegas, Nevada
• The following abstracts have recently been accepted for poster presentation:
Help employers find you! Check out all the jobs and post your resume.
The Fall Clinical Dermatology Conference, October 1-4, 2015 in Las Vegas, Nevada
• The following abstracts have recently been accepted for poster presentation:
Help employers find you! Check out all the jobs and post your resume.
